{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:32:41Z","timestamp":1791358361010,"version":"4.3.1"},"reference-count":182,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,4,20]],"date-time":"2016-04-20T00:00:00Z","timestamp":1461110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,4,20]],"date-time":"2016-04-20T00:00:00Z","timestamp":1461110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["U01AA021723"],"award-info":[{"award-number":["U01AA021723"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R21AA022387"],"award-info":[{"award-number":["R21AA022387"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK104713"],"award-info":[{"award-number":["R01DK104713"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK097075"],"award-info":[{"award-number":["R01DK097075"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["POIHL114457"],"award-info":[{"award-number":["POIHL114457"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL119837"],"award-info":[{"award-number":["R01HL119837"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00109-016-1408-1","type":"journal-article","created":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T21:54:26Z","timestamp":1461102866000},"page":"613-627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":131,"title":["Hypoxia-inducible factors as molecular targets for liver diseases"],"prefix":"10.1007","volume":"94","author":[{"given":"Cynthia","family":"Ju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Colgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger K.","family":"Eltzschig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,20]]},"reference":[{"key":"1408_CR1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaoncol.2015.0735","volume":"1","author":"C Fitzmaurice","year":"2015","unstructured":"Fitzmaurice C, Dicker D, Pain A et al (2015) The global burden of cancer 2013. JAMA Oncol 1:505\u2013527","journal-title":"JAMA Oncol"},{"key":"1408_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/35017054","volume":"2","author":"M Ohh","year":"2000","unstructured":"Ohh M, Park CW, Ivan M et al (2000) Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol 2:423\u2013427","journal-title":"Nat Cell Biol"},{"key":"1408_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/20459","volume":"399","author":"PH Maxwell","year":"1999","unstructured":"Maxwell PH, Wiesener MS, Chang GW et al (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271\u2013275","journal-title":"Nature"},{"key":"1408_CR4","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1101\/gad.991402","volume":"16","author":"D Lando","year":"2002","unstructured":"Lando D, Peet DJ, Gorman JJ et al (2002) FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 16:1466\u20131471","journal-title":"Genes Dev"},{"key":"1408_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3748\/wjg.v10.i4.525","volume":"10","author":"G Bangoura","year":"2004","unstructured":"Bangoura G, Yang LY, Huang GW, Wang W (2004) Expression of HIF-2alpha\/EPAS1 in hepatocellular carcinoma. World J Gastroenterol 10:525\u2013530","journal-title":"World J Gastroenterol"},{"key":"1408_CR6","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1053\/jhep.2002.32524","volume":"35","author":"C Corpechot","year":"2002","unstructured":"Corpechot C, Barbu V, Wendum D et al (2002) Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology 35:1010\u20131021","journal-title":"Hepatology"},{"key":"1408_CR7","doi-asserted-by":"crossref","unstructured":"Hu JL, Liu LP (2015) Yang SL et al. Hepatitis B virus induces hypoxia-inducible factor-2alpha expression through hepatitis B virus X protein. Oncol Rep","DOI":"10.3892\/or.2015.4480"},{"key":"1408_CR8","first-page":"821","volume":"11","author":"S Li","year":"2011","unstructured":"Li S, Yao D, Wang L et al (2011) Expression characteristics of hypoxia-inducible factor-1alpha and its clinical values in diagnosis and prognosis of hepatocellular carcinoma. Hepat Mon 11:821\u2013828","journal-title":"Hepat Mon"},{"key":"1408_CR9","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/bjc.2013.787","volume":"110","author":"LP Liu","year":"2014","unstructured":"Liu LP, Hu BG, Ye C et al (2014) HBx mutants differentially affect the activation of hypoxia-inducible factor-1alpha in hepatocellular carcinoma. Br J Cancer 110:1066\u20131073","journal-title":"Br J Cancer"},{"key":"1408_CR10","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/path.3005","volume":"226","author":"E Novo","year":"2012","unstructured":"Novo E, Povero D, Busletta C et al (2012) The biphasic nature of hypoxia-induced directional migration of activated human hepatic stellate cells. J Pathol 226:588\u2013597","journal-title":"J Pathol"},{"key":"1408_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/hep.510310201","volume":"31","author":"K Jungermann","year":"2000","unstructured":"Jungermann K, Kietzmann T (2000) Oxygen: modulator of metabolic zonation and disease of the liver. Hepatology 31:255\u2013260","journal-title":"Hepatology"},{"key":"1408_CR12","doi-asserted-by":"publisher","first-page":"10249","DOI":"10.1128\/JVI.00763-07","volume":"81","author":"M Nasimuzzaman","year":"2007","unstructured":"Nasimuzzaman M, Waris G, Mikolon D, Stupack DG, Siddiqui A (2007) Hepatitis C virus stabilizes hypoxia-inducible factor 1alpha and stimulates the synthesis of vascular endothelial growth factor. J Virol 81:10249\u201310257","journal-title":"J Virol"},{"key":"1408_CR13","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/hep.24400","volume":"54","author":"A Qu","year":"2011","unstructured":"Qu A, Taylor M, Xue X et al (2011) Hypoxia-inducible transcription factor 2alpha promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis. Hepatology 54:472\u2013483","journal-title":"Hepatology"},{"key":"1408_CR14","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.jhep.2011.11.018","volume":"56","author":"GK Wilson","year":"2012","unstructured":"Wilson GK, Brimacombe CL, Rowe IA et al (2012) A dual role for hypoxia inducible factor-1alpha in the hepatitis C virus lifecycle and hepatoma migration. J Hepatol 56:803\u2013809","journal-title":"J Hepatol"},{"key":"1408_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.immuni.2013.11.020","volume":"40","author":"EL Campbell","year":"2014","unstructured":"Campbell EL, Bruyninckx WJ, Kelly CJ et al (2014) Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation. Immunity 40:66\u201377","journal-title":"Immunity"},{"key":"1408_CR16","doi-asserted-by":"publisher","first-page":"7516","DOI":"10.4049\/jimmunol.178.12.7516","volume":"178","author":"C Peyssonnaux","year":"2007","unstructured":"Peyssonnaux C, Cejudo-Martin P, Doedens A et al (2007) Cutting edge: essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis. J Immunol 178:7516\u20137519","journal-title":"J Immunol"},{"key":"1408_CR17","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1042\/BJ20051839","volume":"396","author":"S Frede","year":"2006","unstructured":"Frede S, Stockmann C, Freitag P, Fandrey J (2006) Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44\/42 MAPK and NF-kappaB. Biochem J 396:517\u2013527","journal-title":"Biochem J"},{"key":"1408_CR18","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1182\/blood-2003-07-2427","volume":"103","author":"CC Blouin","year":"2004","unstructured":"Blouin CC, Page EL, Soucy GM, Richard DE (2004) Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1alpha. Blood 103:1124\u20131130","journal-title":"Blood"},{"key":"1408_CR19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature11986","volume":"496","author":"GM Tannahill","year":"2013","unstructured":"Tannahill GM, Curtis AM, Adamik J et al (2013) Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Nature 496:238\u2013242","journal-title":"Nature"},{"key":"1408_CR20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.cmet.2005.05.001","volume":"1","author":"RD Guzy","year":"2005","unstructured":"Guzy RD, Hoyos B, Robin E et al (2005) Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab 1:401\u2013408","journal-title":"Cell Metab"},{"key":"1408_CR21","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S0092-8674(03)00154-5","volume":"112","author":"T Cramer","year":"2003","unstructured":"Cramer T, Yamanishi Y, Clausen BE et al (2003) HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112:645\u2013657","journal-title":"Cell"},{"key":"1408_CR22","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/414916a","volume":"414","author":"A Ohta","year":"2001","unstructured":"Ohta A, Sitkovsky M (2001) Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414:916\u2013920","journal-title":"Nature"},{"key":"1408_CR23","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/mi.2015.41","volume":"8","author":"CM Aherne","year":"2015","unstructured":"Aherne CM, Saeedi B, Collins CB et al (2015) Epithelial-specific A2B adenosine receptor signaling protects the colonic epithelial barrier during acute colitis. Mucosal Immunol 8:699","journal-title":"Mucosal Immunol"},{"key":"1408_CR24","doi-asserted-by":"publisher","first-page":"E2784","DOI":"10.1073\/pnas.1202366109","volume":"109","author":"ET Clambey","year":"2012","unstructured":"Clambey ET, McNamee EN, Westrich JA et al (2012) Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa. Proc Natl Acad Sci U S A 109:E2784\u2013E2793","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1408_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev-physiol-020911-153230","volume":"74","author":"SP Colgan","year":"2012","unstructured":"Colgan SP, Eltzschig HK (2012) Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery. Annu Rev Physiol 74:153\u2013175","journal-title":"Annu Rev Physiol"},{"key":"1408_CR26","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/nm.2507","volume":"17","author":"HK Eltzschig","year":"2011","unstructured":"Eltzschig HK, Eckle T (2011) Ischemia and reperfusion\u2014from mechanism to translation. Nat Med 17:1391\u20131401","journal-title":"Nat Med"},{"key":"1408_CR27","first-page":"1329","volume":"2011","author":"CM Aherne","year":"1808","unstructured":"Aherne CM, Kewley EM, Eltzschig HK (1808) The resurgence of A2B adenosine receptor signaling. Biochim Biophys Acta 2011:1329\u20131339","journal-title":"Biochim Biophys Acta"},{"key":"1408_CR28","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.molmed.2013.02.005","volume":"19","author":"HK Eltzschig","year":"2013","unstructured":"Eltzschig HK, Bonney SK, Eckle T (2013) Attenuating myocardial ischemia by targeting A2B adenosine receptors. Trends Mol Med 19:345\u2013354","journal-title":"Trends Mol Med"},{"key":"1408_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/00007890-199001000-00023","volume":"49","author":"TK Howard","year":"1990","unstructured":"Howard TK, Klintmalm GB, Cofer JB et al (1990) The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation 49:103\u2013107","journal-title":"Transplantation"},{"key":"1408_CR30","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/j.jss.2010.10.013","volume":"172","author":"Y Chen","year":"2012","unstructured":"Chen Y, Xie X (2012) Tacrolimus attenuates myocardium damage to the total hepatic ischemia-reperfusion via regulation of the mitochondrial function. J Surg Res 172:e47\u2013e54","journal-title":"J Surg Res"},{"key":"1408_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/S0002-9610(00)00573-0","volume":"181","author":"F Serracino-Inglott","year":"2001","unstructured":"Serracino-Inglott F, Habib NA, Mathie RT (2001) Hepatic ischemia-reperfusion injury. Am J Surg 181:160\u2013166","journal-title":"Am J Surg"},{"key":"1408_CR32","doi-asserted-by":"publisher","first-page":"e2468","DOI":"10.1371\/journal.pone.0002468","volume":"3","author":"JE Stahl","year":"2008","unstructured":"Stahl JE, Kreke JE, Malek FA, Schaefer AJ, Vacanti J (2008) Consequences of cold-ischemia time on primary nonfunction and patient and graft survival in liver transplantation: a meta-analysis. PLoS One 3:e2468","journal-title":"PLoS One"},{"key":"1408_CR33","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1001\/archsurg.2011.240","volume":"146","author":"JC Hong","year":"2011","unstructured":"Hong JC, Yersiz H, Kositamongkol P et al (2011) Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival. Arch Surg 146:1017\u20131023","journal-title":"Arch Surg"},{"key":"1408_CR34","doi-asserted-by":"publisher","first-page":"e50235","DOI":"10.1371\/journal.pone.0050235","volume":"7","author":"MI Ben","year":"2012","unstructured":"Ben MI, Mouchel Y, Pajaud J et al (2012) Pretreatment with mangafodipir improves liver graft tolerance to ischemia\/reperfusion injury in rat. PLoS One 7:e50235","journal-title":"PLoS One"},{"key":"1408_CR35","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1042\/CS20130025","volume":"126","author":"YY Yang","year":"2014","unstructured":"Yang YY, Lee PC, Huang YT et al (2014) Involvement of the HIF-1alpha and Wnt\/beta-catenin pathways in the protective effects of losartan on fatty liver graft with ischaemia\/reperfusion injury. Clin Sci (Lond) 126:163\u2013174","journal-title":"Clin Sci (Lond)"},{"key":"1408_CR36","doi-asserted-by":"publisher","first-page":"G823","DOI":"10.1152\/ajpgi.90287.2008","volume":"295","author":"Z Zhong","year":"2008","unstructured":"Zhong Z, Ramshesh VK, Rehman H et al (2008) Activation of the oxygen-sensing signal cascade prevents mitochondrial injury after mouse liver ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol 295:G823\u2013G832","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1408_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3727\/096504013X13589503482815","volume":"20","author":"Z Xu","year":"2012","unstructured":"Xu Z, Chen X, Peng C et al (2012) Hypoxia-inducible factor-1alpha suppressed hepatocellular carcinoma cell apoptosis through influencing on Omi\/HtrA2 expression and its releasing from the mitochondrion. Oncol Res 20:213\u2013220","journal-title":"Oncol Res"},{"key":"1408_CR38","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/jcb.24757","volume":"115","author":"W Yoo","year":"2014","unstructured":"Yoo W, Noh KH, Ahn JH et al (2014) HIF-1alpha expression as a protective strategy of HepG2 cells against fatty acid-induced toxicity. J Cell Biochem 115:1147\u20131158","journal-title":"J Cell Biochem"},{"key":"1408_CR39","doi-asserted-by":"publisher","first-page":"18154","DOI":"10.1073\/pnas.0602235103","volume":"103","author":"EP Cummins","year":"2006","unstructured":"Cummins EP, Berra E, Comerford KM et al (2006) Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc Natl Acad Sci U S A 103:18154\u201318159","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1408_CR40","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1053\/j.gastro.2010.06.068","volume":"139","author":"MM Tambuwala","year":"2010","unstructured":"Tambuwala MM, Cummins EP, Lenihan CR et al (2010) Loss of prolyl hydroxylase-1 protects against colitis through reduced epithelial cell apoptosis and increased barrier function. Gastroenterology 139:2093\u20132101","journal-title":"Gastroenterology"},{"key":"1408_CR41","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1053\/j.gastro.2009.09.057","volume":"138","author":"M Schneider","year":"2010","unstructured":"Schneider M, Van GK, Fraisl P et al (2010) Loss or silencing of the PHD1 prolyl hydroxylase protects livers of mice against ischemia\/reperfusion injury. Gastroenterology 138:1143\u20131154","journal-title":"Gastroenterology"},{"key":"1408_CR42","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00423-012-0998-5","volume":"397","author":"M Mollenhauer","year":"2012","unstructured":"Mollenhauer M, Kiss J, Dudda J et al (2012) Deficiency of the oxygen sensor PHD1 augments liver regeneration after partial hepatectomy. Langenbecks Arch Surg 397:1313\u20131322","journal-title":"Langenbecks Arch Surg"},{"key":"1408_CR43","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nature13085","volume":"509","author":"M Idzko","year":"2014","unstructured":"Idzko M, Ferrari D, Eltzschig HK (2014) Nucleotide signalling during inflammation. Nature 509:310\u2013317","journal-title":"Nature"},{"key":"1408_CR44","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1182\/blood-2013-09-402560","volume":"124","author":"M Idzko","year":"2014","unstructured":"Idzko M, Ferrari D, Riegel AK, Eltzschig HK (2014) Extracellular nucleotide and nucleoside signaling in vascular and blood disease. Blood 124:1029\u20131037","journal-title":"Blood"},{"key":"1408_CR45","doi-asserted-by":"publisher","first-page":"4017","DOI":"10.4049\/jimmunol.0901851","volume":"184","author":"ML Hart","year":"2010","unstructured":"Hart ML, Gorzolla IC, Schittenhelm J, Robson SC, Eltzschig HK (2010) SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning. J Immunol 184:4017\u20134024","journal-title":"J Immunol"},{"key":"1408_CR46","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1096\/fj.07-103911","volume":"22","author":"ML Hart","year":"2008","unstructured":"Hart ML, Henn M, Kohler D et al (2008) Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury. FASEB J 22:2784\u20132797","journal-title":"FASEB J"},{"key":"1408_CR47","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1053\/j.gastro.2008.07.064","volume":"135","author":"ML Hart","year":"2008","unstructured":"Hart ML, Much C, Gorzolla IC et al (2008) Extracellular adenosine production by ecto-5'-nucleotidase protects during murine hepatic ischemic preconditioning. Gastroenterology 135:1739\u20131750","journal-title":"Gastroenterology"},{"key":"1408_CR48","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1056\/NEJMra0910283","volume":"364","author":"HK Eltzschig","year":"2011","unstructured":"Eltzschig HK, Carmeliet P (2011) Hypoxia and inflammation. N Engl J Med 364:656\u2013665","journal-title":"N Engl J Med"},{"key":"1408_CR49","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1056\/NEJMra1205750","volume":"367","author":"HK Eltzschig","year":"2012","unstructured":"Eltzschig HK, Sitkovsky MV, Robson SC (2012) Purinergic signaling during inflammation. N Engl J Med 367:2322\u20132333","journal-title":"N Engl J Med"},{"key":"1408_CR50","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1097\/TP.0b013e31826a9a46","volume":"94","author":"A Chouker","year":"2012","unstructured":"Chouker A, Ohta A, Martignoni A et al (2012) In vivo hypoxic preconditioning protects from warm liver ischemia-reperfusion injury through the adenosine A2B receptor. Transplantation 94:894\u2013902","journal-title":"Transplantation"},{"key":"1408_CR51","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1084\/jem.20030891","volume":"198","author":"HK Eltzschig","year":"2003","unstructured":"Eltzschig HK, Ibla JC, Furuta GT et al (2003) Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J Exp Med 198:783\u2013796","journal-title":"J Exp Med"},{"key":"1408_CR52","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1096\/fj.06-6419com","volume":"20","author":"T Kong","year":"2006","unstructured":"Kong T, Westerman KA, Faigle M, Eltzschig HK, Colgan SP (2006) HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J 20:2242\u20132250","journal-title":"FASEB J"},{"key":"1408_CR53","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1084\/jem.20061097","volume":"203","author":"CM Lappas","year":"2006","unstructured":"Lappas CM, Day YJ, Marshall MA, Engelhard VH, Linden J (2006) Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. J Exp Med 203:2639\u20132648","journal-title":"J Exp Med"},{"key":"1408_CR54","doi-asserted-by":"publisher","first-page":"10684","DOI":"10.1073\/pnas.0901326106","volume":"106","author":"A Ahmad","year":"2009","unstructured":"Ahmad A, Ahmad S, Glover L et al (2009) Adenosine A2A receptor is a unique angiogenic target of HIF-2alpha in pulmonary endothelial cells. Proc Natl Acad Sci U S A 106:10684\u201310689","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1408_CR55","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1084\/jem.20050177","volume":"202","author":"HK Eltzschig","year":"2005","unstructured":"Eltzschig HK, Abdulla P, Hoffman E et al (2005) HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J Exp Med 202:1493\u20131505","journal-title":"J Exp Med"},{"key":"1408_CR56","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1165\/rcmb.2012-0457OC","volume":"49","author":"JC Morote-Garcia","year":"2013","unstructured":"Morote-Garcia JC, Kohler D, Roth JM et al (2013) Repression of the equilibrative nucleoside transporters dampens inflammatory lung injury. Am J Respir Cell Mol Biol 49:296\u2013305","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1408_CR57","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1423-0127-18-79","volume":"18","author":"JY Guo","year":"2011","unstructured":"Guo JY, Yang T, Sun XG et al (2011) Ischemic postconditioning attenuates liver warm ischemia-reperfusion injury through Akt-eNOS-NO-HIF pathway. J Biomed Sci 18:79","journal-title":"J Biomed Sci"},{"key":"1408_CR58","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jhep.2007.04.016","volume":"47","author":"J Plock","year":"2007","unstructured":"Plock J, Frese S, Keogh A et al (2007) Activation of non-ischemic, hypoxia-inducible signalling pathways up-regulate cytoprotective genes in the murine liver. J Hepatol 47:538\u2013545","journal-title":"J Hepatol"},{"key":"1408_CR59","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1111\/j.1600-6143.2007.01914.x","volume":"7","author":"A Amador","year":"2007","unstructured":"Amador A, Grande L, Marti J et al (2007) Ischemic pre-conditioning in deceased donor liver transplantation: a prospective randomized clinical trial. Am J Transplant 7:2180\u20132189","journal-title":"Am J Transplant"},{"key":"1408_CR60","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/nrd4422","volume":"13","author":"HK Eltzschig","year":"2014","unstructured":"Eltzschig HK, Bratton DL, Colgan SP (2014) Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases. Nat Rev Drug Discov 13:852\u2013869","journal-title":"Nat Rev Drug Discov"},{"key":"1408_CR61","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/hep.20734","volume":"42","author":"G Bedogni","year":"2005","unstructured":"Bedogni G, Miglioli L, Masutti F et al (2005) Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42:44\u201352","journal-title":"Hepatology"},{"key":"1408_CR62","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/BF02777789","volume":"27","author":"A Nonomura","year":"1992","unstructured":"Nonomura A, Mizukami Y, Unoura M et al (1992) Clinicopathologic study of alcohol-like liver disease in non-alcoholics; non-alcoholic steatohepatitis and fibrosis. Gastroenterol Jpn 27:521\u2013528","journal-title":"Gastroenterol Jpn"},{"key":"1408_CR63","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1046\/j.1440-1746.2002.02846.x","volume":"17","author":"K Omagari","year":"2002","unstructured":"Omagari K, Kadokawa Y, Masuda J et al (2002) Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J Gastroenterol Hepatol 17:1098\u20131105","journal-title":"J Gastroenterol Hepatol"},{"key":"1408_CR64","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1751-2980.2010.00469.x","volume":"12","author":"AJ McCullough","year":"2011","unstructured":"McCullough AJ (2011) Epidemiology of the metabolic syndrome in the USA. J Dig Dis 12:333\u2013340","journal-title":"J Dig Dis"},{"key":"1408_CR65","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1053\/j.gastro.2008.02.077","volume":"134","author":"DM Torres","year":"2008","unstructured":"Torres DM, Harrison SA (2008) Diagnosis and therapy of nonalcoholic steatohepatitis. Gastroenterology 134:1682\u20131698","journal-title":"Gastroenterology"},{"key":"1408_CR66","doi-asserted-by":"publisher","first-page":"E462","DOI":"10.1152\/ajpendo.00064.2004","volume":"288","author":"LS Szczepaniak","year":"2005","unstructured":"Szczepaniak LS, Nurenberg P, Leonard D et al (2005) Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288:E462\u2013E468","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1408_CR67","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.cld.2009.07.005","volume":"13","author":"CK Argo","year":"2009","unstructured":"Argo CK, Caldwell SH (2009) Epidemiology and natural history of non-alcoholic steatohepatitis. Clin Liver Dis 13:511\u2013531","journal-title":"Clin Liver Dis"},{"key":"1408_CR68","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1053\/jhep.2003.50320","volume":"38","author":"JM Hui","year":"2003","unstructured":"Hui JM, Kench JG, Chitturi S et al (2003) Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology 38:420\u2013427","journal-title":"Hepatology"},{"key":"1408_CR69","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","volume":"129","author":"LA Adams","year":"2005","unstructured":"Adams LA, Lymp JF, St SJ et al (2005) The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129:113\u2013121","journal-title":"Gastroenterology"},{"key":"1408_CR70","doi-asserted-by":"publisher","first-page":"31995","DOI":"10.1074\/jbc.M110.124164","volume":"285","author":"N Nasrin","year":"2010","unstructured":"Nasrin N, Wu X, Fortier E et al (2010) SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells. J Biol Chem 285:31995\u201332002","journal-title":"J Biol Chem"},{"key":"1408_CR71","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-1-4419-1241-1_10","volume":"662","author":"K Kondo","year":"2010","unstructured":"Kondo K, Sugioka T, Tsukada K et al (2010) Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, improves hepatic microcirculatory patency and oxygen availability in a high-fat-diet-induced fatty liver in mice. Adv Exp Med Biol 662:77\u201382","journal-title":"Adv Exp Med Biol"},{"key":"1408_CR72","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0167-4889(93)90216-C","volume":"1175","author":"DC Henly","year":"1993","unstructured":"Henly DC, Berry MN (1993) Effect of palmitate concentration on the relative contributions of the beta-oxidation pathway and citric acid cycle to total O2 consumption of isolated rat hepatocytes. Biochim Biophys Acta 1175:269\u2013276","journal-title":"Biochim Biophys Acta"},{"key":"1408_CR73","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1042\/CS20090313","volume":"118","author":"AC Piguet","year":"2010","unstructured":"Piguet AC, Stroka D, Zimmermann A, Dufour JF (2010) Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN. Clin Sci (Lond) 118:401\u2013410","journal-title":"Clin Sci (Lond)"},{"key":"1408_CR74","first-page":"663","volume":"88","author":"GB Gordon","year":"1977","unstructured":"Gordon GB, Barcza MA, Bush ME (1977) Lipid accumulation of hypoxic tissue culture cells. Am J Pathol 88:663\u2013678","journal-title":"Am J Pathol"},{"key":"1408_CR75","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1161\/CIRCRESAHA.111.246363","volume":"109","author":"S Parathath","year":"2011","unstructured":"Parathath S, Mick SL, Feig JE et al (2011) Hypoxia is present in murine atherosclerotic plaques and has multiple adverse effects on macrophage lipid metabolism. Circ Res 109:1141\u20131152","journal-title":"Circ Res"},{"key":"1408_CR76","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1158\/0008-5472.CAN-07-2489","volume":"68","author":"E Furuta","year":"2008","unstructured":"Furuta E, Pai SK, Zhan R et al (2008) Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Res 68:1003\u20131011","journal-title":"Cancer Res"},{"key":"1408_CR77","doi-asserted-by":"publisher","first-page":"5729","DOI":"10.1128\/MCB.00331-09","volume":"29","author":"YA Minamishima","year":"2009","unstructured":"Minamishima YA, Moslehi J, Padera RF et al (2009) A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo. Mol Cell Biol 29:5729\u20135741","journal-title":"Mol Cell Biol"},{"key":"1408_CR78","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1128\/MCB.00200-09","volume":"29","author":"EB Rankin","year":"2009","unstructured":"Rankin EB, Rha J, Selak MA et al (2009) Hypoxia-inducible factor 2 regulates hepatic lipid metabolism. Mol Cell Biol 29:4527\u20134538","journal-title":"Mol Cell Biol"},{"key":"1408_CR79","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1038\/sj.emboj.7601300","volume":"25","author":"WY Kim","year":"2006","unstructured":"Kim WY, Safran M, Buckley MR et al (2006) Failure to prolyl hydroxylate hypoxia-inducible factor alpha phenocopies VHL inactivation in vivo. EMBO J 25:4650\u20134662","journal-title":"EMBO J"},{"key":"1408_CR80","doi-asserted-by":"publisher","first-page":"15087","DOI":"10.3748\/wjg.v20.i41.15087","volume":"20","author":"T Suzuki","year":"2014","unstructured":"Suzuki T, Shinjo S, Arai T, Kanai M, Goda N (2014) Hypoxia and fatty liver. World J Gastroenterol 20:15087\u201315097","journal-title":"World J Gastroenterol"},{"key":"1408_CR81","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1055\/s-2004-832936","volume":"24","author":"S Mandayam","year":"2004","unstructured":"Mandayam S, Jamal MM, Morgan TR (2004) Epidemiology of alcoholic liver disease. Semin Liver Dis 24:217\u2013232","journal-title":"Semin Liver Dis"},{"key":"1408_CR82","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/hep.23258","volume":"51","author":"RS O\u2019Shea","year":"2010","unstructured":"O\u2019Shea RS, Dasarathy S, McCullough AJ (2010) Alcoholic liver disease. Hepatology 51:307\u2013328","journal-title":"Hepatology"},{"key":"1408_CR83","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","volume":"141","author":"B Gao","year":"2011","unstructured":"Gao B, Bataller R (2011) Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141:1572\u20131585","journal-title":"Gastroenterology"},{"key":"1408_CR84","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1053\/jhep.2002.31782","volume":"35","author":"B Raynard","year":"2002","unstructured":"Raynard B, Balian A, Fallik D et al (2002) Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 35:635\u2013638","journal-title":"Hepatology"},{"key":"1408_CR85","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/hep.510250120","volume":"25","author":"S Naveau","year":"1997","unstructured":"Naveau S, Giraud V, Borotto E et al (1997) Excess weight risk factor for alcoholic liver disease. Hepatology 25:108\u2013111","journal-title":"Hepatology"},{"key":"1408_CR86","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1055\/s-0029-1214374","volume":"29","author":"L Siu","year":"2009","unstructured":"Siu L, Foont J, Wands JR (2009) Hepatitis C virus and alcohol. Semin Liver Dis 29:188\u2013199","journal-title":"Semin Liver Dis"},{"key":"1408_CR87","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1042\/bj1860119","volume":"186","author":"T Yuki","year":"1980","unstructured":"Yuki T, Thurman RG (1980) The swift increase in alcohol metabolism. Time course for the increase in hepatic oxygen uptake and the involvement of glycolysis. Biochem J 186:119\u2013126","journal-title":"Biochem J"},{"key":"1408_CR88","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1042\/bj1340523","volume":"134","author":"Y Israel","year":"1973","unstructured":"Israel Y, Videla L, Macdonald A, Bernstein J (1973) Metabolic alterations produced in the liver by chronic ethanol administration. Comparison between the effects produced by ethanol and by thyroid hormones. Biochem J 134:523\u2013529","journal-title":"Biochem J"},{"key":"1408_CR89","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.hepres.2004.02.006","volume":"29","author":"SW French","year":"2004","unstructured":"French SW (2004) The role of hypoxia in the pathogenesis of alcoholic liver disease. Hepatol Res 29:69\u201374","journal-title":"Hepatol Res"},{"key":"1408_CR90","first-page":"G494","volume":"271","author":"GE Arteel","year":"1996","unstructured":"Arteel GE, Raleigh JA, Bradford BU, Thurman RG (1996) Acute alcohol produces hypoxia directly in rat liver tissue in vivo: role of Kupffer cells. Am J Physiol 271:G494\u2013G500","journal-title":"Am J Physiol"},{"key":"1408_CR91","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/hep.510250422","volume":"25","author":"GE Arteel","year":"1997","unstructured":"Arteel GE, Iimuro Y, Yin M, Raleigh JA, Thurman RG (1997) Chronic enteral ethanol treatment causes hypoxia in rat liver tissue in vivo. Hepatology 25:920\u2013926","journal-title":"Hepatology"},{"key":"1408_CR92","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jhep.2011.07.024","volume":"56","author":"Y Nishiyama","year":"2012","unstructured":"Nishiyama Y, Goda N, Kanai M et al (2012) HIF-1alpha induction suppresses excessive lipid accumulation in alcoholic fatty liver in mice. J Hepatol 56:441\u2013447","journal-title":"J Hepatol"},{"key":"1408_CR93","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1002\/hep.24256","volume":"53","author":"B Nath","year":"2011","unstructured":"Nath B, Levin I, Csak T et al (2011) Hepatocyte-specific hypoxia-inducible factor-1alpha is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice. Hepatology 53:1526\u20131537","journal-title":"Hepatology"},{"key":"1408_CR94","first-page":"560","volume":"5","author":"L Li","year":"2006","unstructured":"Li L, Chen SH, Zhang Y et al (2006) Is the hypoxia-inducible factor-1 alpha mRNA expression activated by ethanol-induced injury, the mechanism underlying alcoholic liver disease? Hepatobiliary Pancreat Dis Int 5:560\u2013563","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"1408_CR95","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1042\/cs0920103","volume":"92","author":"R Alcolado","year":"1997","unstructured":"Alcolado R, Arthur MJ, Iredale JP (1997) Pathogenesis of liver fibrosis. Clin Sci (Lond) 92:103\u2013112","journal-title":"Clin Sci (Lond)"},{"issue":"Suppl 1","key":"1408_CR96","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/S0168-8278(02)00427-0","volume":"38","author":"SF Stewart","year":"2003","unstructured":"Stewart SF, Day CP (2003) The management of alcoholic liver disease. JHepatol 38(Suppl 1):S2\u201313","journal-title":"J.Hepatol"},{"key":"1408_CR97","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1478-3231.2010.02369.x","volume":"31","author":"S Coulon","year":"2011","unstructured":"Coulon S, Heindryckx F, Geerts A et al (2011) Angiogenesis in chronic liver disease and its complications. Liver Int 31:146\u2013162","journal-title":"Liver Int"},{"key":"1408_CR98","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1053\/j.seminoncol.2012.05.006","volume":"39","author":"G Cabibbo","year":"2012","unstructured":"Cabibbo G, Maida M, Genco C, Antonucci M, Camma C (2012) Causes of and prevention strategies for hepatocellular carcinoma. Semin Oncol 39:374\u2013383","journal-title":"Semin Oncol"},{"issue":"Suppl 19","key":"1408_CR99","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00535-008-2262-x","volume":"44","author":"E Hashimoto","year":"2009","unstructured":"Hashimoto E, Yatsuji S, Tobari M et al (2009) Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J Gastroenterol 44(Suppl 19):89\u201395","journal-title":"J Gastroenterol"},{"key":"1408_CR100","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/026119290102900324","volume":"29","author":"T Vanhaecke","year":"2001","unstructured":"Vanhaecke T, Foriers A, Geerts A et al (2001) Pyruvate-induced long-term maintenance of glutathione s-transferase in rat hepatocyte cultures. Altern Lab Anim 29:335\u2013346","journal-title":"Altern Lab Anim"},{"key":"1408_CR101","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0168-8278(00)80007-0","volume":"33","author":"P Onori","year":"2000","unstructured":"Onori P, Morini S, Franchitto A et al (2000) Hepatic microvascular features in experimental cirrhosis: a structural and morphometrical study in CCl4-treated rats. J Hepatol 33:555\u2013563","journal-title":"J Hepatol"},{"key":"1408_CR102","first-page":"G582","volume":"296","author":"JO Moon","year":"2009","unstructured":"Moon JO, Welch TP, Gonzalez FJ, Copple BL (2009) Reduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient mice. Am.J Physiol Gastrointest. Liver Physiol 296:G582\u2013G592","journal-title":"Liver Physiol"},{"key":"1408_CR103","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.2353\/ajpath.2007.060887","volume":"170","author":"E Novo","year":"2007","unstructured":"Novo E, Cannito S, Zamara E et al (2007) Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells. Am J Pathol 170:1942\u20131953","journal-title":"Am J Pathol"},{"key":"1408_CR104","doi-asserted-by":"publisher","first-page":"e00061","DOI":"10.1002\/prp2.61","volume":"2","author":"S Roychowdhury","year":"2014","unstructured":"Roychowdhury S, Chiang DJ, McMullen MR, Nagy LE (2014) Moderate, chronic ethanol feeding exacerbates carbon-tetrachloride-induced hepatic fibrosis via hepatocyte-specific hypoxia inducible factor 1alpha. Pharmacol Res Perspect 2:e00061","journal-title":"Pharmacol Res Perspect"},{"key":"1408_CR105","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1124\/jpet.111.189340","volume":"341","author":"BL Copple","year":"2012","unstructured":"Copple BL, Kaska S, Wentling C (2012) Hypoxia-inducible factor activation in myeloid cells contributes to the development of liver fibrosis in cholestatic mice. J Pharmacol Exp Ther 341:307\u2013316","journal-title":"J Pharmacol Exp Ther"},{"key":"1408_CR106","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/sj.bjp.0706812","volume":"148","author":"ES Chan","year":"2006","unstructured":"Chan ES, Montesinos MC, Fernandez P et al (2006) Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis. Br J Pharmacol 148:1144\u20131155","journal-title":"Br J Pharmacol"},{"key":"1408_CR107","doi-asserted-by":"publisher","first-page":"e69114","DOI":"10.1371\/journal.pone.0069114","volume":"8","author":"DJ Chiang","year":"2013","unstructured":"Chiang DJ, Roychowdhury S, Bush K et al (2013) Adenosine 2A receptor antagonist prevented and reversed liver fibrosis in a mouse model of ethanol-exacerbated liver fibrosis. PLoS ONE 8:e69114","journal-title":"PLoS ONE"},{"key":"1408_CR108","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1124\/jpet.106.112250","volume":"320","author":"SJ Mustafa","year":"2007","unstructured":"Mustafa SJ, Nadeem A, Fan M et al (2007) Effect of a specific and selective A(2B) adenosine receptor antagonist on adenosine agonist AMP and allergen-induced airway responsiveness and cellular influx in a mouse model of asthma. J Pharmacol Exp Ther 320:1246\u20131251","journal-title":"J Pharmacol Exp Ther"},{"key":"1408_CR109","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.tcm.2005.02.002","volume":"15","author":"DJ Ceradini","year":"2005","unstructured":"Ceradini DJ, Gurtner GC (2005) Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med 15:57\u201363","journal-title":"Trends Cardiovasc Med"},{"key":"1408_CR110","first-page":"3810","volume":"117","author":"DF Higgins","year":"2007","unstructured":"Higgins DF, Kimura K, Bernhardt WM et al (2007) Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 117:3810\u20133820","journal-title":"J Clin Invest"},{"key":"1408_CR111","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/ki.2009.62","volume":"75","author":"S Sun","year":"2009","unstructured":"Sun S, Ning X, Zhang Y et al (2009) Hypoxia-inducible factor-1alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition. Kidney Int 75:1278\u20131287","journal-title":"Kidney Int"},{"key":"1408_CR112","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jhep.2014.08.025","volume":"61","author":"GK Wilson","year":"2014","unstructured":"Wilson GK, Tennant DA, McKeating JA (2014) Hypoxia inducible factors in liver disease and hepatocellular carcinoma: current understanding and future directions. J Hepatol 61:1397\u20131406","journal-title":"J Hepatol"},{"key":"1408_CR113","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","volume":"142","author":"HB El-Serag","year":"2012","unstructured":"El-Serag HB (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142:1264\u20131273","journal-title":"Gastroenterology"},{"key":"1408_CR114","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1046\/j.1440-1746.2000.02069.x","volume":"15","author":"P Arbuthnot","year":"2000","unstructured":"Arbuthnot P, Capovilla A, Kew M (2000) Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK\/STAT pathways. J Gastroenterol Hepatol 15:357\u2013368","journal-title":"J Gastroenterol Hepatol"},{"key":"1408_CR115","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1128\/JVI.00769-09","volume":"84","author":"M Ripoli","year":"2010","unstructured":"Ripoli M, D\u2019Aprile A, Quarato G et al (2010) Hepatitis C virus-linked mitochondrial dysfunction promotes hypoxia-inducible factor 1 alpha-mediated glycolytic adaptation. J Virol 84:647\u2013660","journal-title":"J Virol"},{"key":"1408_CR116","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s12032-014-0200-8","volume":"31","author":"Y Liu","year":"2014","unstructured":"Liu Y, Sui J, Zhai L et al (2014) Genetic polymorphisms in hypoxia-inducible factor-1a gene and its association with HBV-related hepatocellular carcinoma in a Chinese population. Med Oncol 31:200","journal-title":"Med Oncol"},{"key":"1408_CR117","first-page":"382","volume":"18","author":"EJ Moon","year":"2004","unstructured":"Moon EJ, Jeong CH, Jeong JW et al (2004) Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1alpha. FASEB J 18:382\u2013384","journal-title":"FASEB J"},{"key":"1408_CR118","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.febslet.2004.10.004","volume":"577","author":"YG Yoo","year":"2004","unstructured":"Yoo YG, Cho S, Park S, Lee MO (2004) The carboxy-terminus of the hepatitis B virus X protein is necessary and sufficient for the activation of hypoxia-inducible factor-1alpha. FEBS Lett 577:121\u2013126","journal-title":"FEBS Lett"},{"key":"1408_CR119","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1038\/sj.onc.1211000","volume":"27","author":"YG Yoo","year":"2008","unstructured":"Yoo YG, Na TY, Seo HW et al (2008) Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells. Oncogene 27:3405\u20133413","journal-title":"Oncogene"},{"key":"1408_CR120","doi-asserted-by":"publisher","first-page":"39076","DOI":"10.1074\/jbc.M305101200","volume":"278","author":"YG Yoo","year":"2003","unstructured":"Yoo YG, Oh SH, Park ES et al (2003) Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1alpha through activation of mitogen-activated protein kinase pathway. J Biol Chem 278:39076\u201339084","journal-title":"J Biol Chem"},{"key":"1408_CR121","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1128\/JVI.02534-12","volume":"87","author":"N Vassilaki","year":"2013","unstructured":"Vassilaki N, Kalliampakou KI, Kotta-Loizou I et al (2013) Low oxygen tension enhances hepatitis C virus replication. J Virol 87:2935\u20132948","journal-title":"J Virol"},{"key":"1408_CR122","doi-asserted-by":"publisher","first-page":"6211","DOI":"10.1128\/JVI.00246-09","volume":"83","author":"CJ Mee","year":"2009","unstructured":"Mee CJ, Harris HJ, Farquhar MJ et al (2009) Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells. J Virol 83:6211\u20136221","journal-title":"J Virol"},{"key":"1408_CR123","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1053\/j.gastro.2009.11.047","volume":"138","author":"CJ Mee","year":"2010","unstructured":"Mee CJ, Farquhar MJ, Harris HJ et al (2010) Hepatitis C virus infection reduces hepatocellular polarity in a vascular endothelial growth factor-dependent manner. Gastroenterology 138:1134\u20131142","journal-title":"Gastroenterology"},{"key":"1408_CR124","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s11302-014-9427-2","volume":"10","author":"G Burnstock","year":"2014","unstructured":"Burnstock G, Boeynaems JM (2014) Purinergic signalling and immune cells. Purinergic Signal 10:529\u2013564","journal-title":"Purinergic Signal"},{"key":"1408_CR125","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1158\/2326-6066.CIR-14-0075","volume":"2","author":"MV Sitkovsky","year":"2014","unstructured":"Sitkovsky MV, Hatfield S, Abbott R et al (2014) Hostile, hypoxia-A2-adenosinergic tumor biology as the next barrier to overcome for tumor immunologists. Cancer Immunol Res 2:598\u2013605","journal-title":"Cancer Immunol Res"},{"key":"1408_CR126","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69\u201390","journal-title":"CA Cancer J Clin"},{"key":"1408_CR127","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","volume":"132","author":"HB El-Serag","year":"2007","unstructured":"El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557\u20132576","journal-title":"Gastroenterology"},{"key":"1408_CR128","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1470-2045(01)00486-7","volume":"2","author":"DM Parkin","year":"2001","unstructured":"Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2:533\u2013543","journal-title":"Lancet Oncol"},{"key":"1408_CR129","doi-asserted-by":"publisher","first-page":"4300","DOI":"10.3748\/wjg.14.4300","volume":"14","author":"AI Gomaa","year":"2008","unstructured":"Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD (2008) Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol 14:4300\u20134308","journal-title":"World J Gastroenterol"},{"key":"1408_CR130","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1002\/hep.22580","volume":"48","author":"RN Aravalli","year":"2008","unstructured":"Aravalli RN, Steer CJ, Cressman EN (2008) Molecular mechanisms of hepatocellular carcinoma. Hepatology 48:2047\u20132063","journal-title":"Hepatology"},{"key":"1408_CR131","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1365-2036.2009.04200.x","volume":"31","author":"R Cabrera","year":"2010","unstructured":"Cabrera R, Nelson DR (2010) Review article: the management of hepatocellular carcinoma. Aliment Pharmacol Ther 31:461\u2013476","journal-title":"Aliment Pharmacol Ther"},{"key":"1408_CR132","doi-asserted-by":"publisher","first-page":"8103","DOI":"10.1007\/s13277-014-2056-0","volume":"35","author":"Y Liu","year":"2014","unstructured":"Liu Y, Liu Y, Yan X et al (2014) HIFs enhance the migratory and neoplastic capacities of hepatocellular carcinoma cells by promoting EMT. Tumour Biol 35:8103\u20138114","journal-title":"Tumour Biol"},{"key":"1408_CR133","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.3748\/wjg.v13.i23.3176","volume":"13","author":"G Bangoura","year":"2007","unstructured":"Bangoura G, Liu ZS, Qian Q et al (2007) Prognostic significance of HIF-2alpha\/EPAS1 expression in hepatocellular carcinoma. World J Gastroenterol 13:3176\u20133182","journal-title":"World J Gastroenterol"},{"key":"1408_CR134","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00423-009-0590-9","volume":"395","author":"F Simon","year":"2010","unstructured":"Simon F, Bockhorn M, Praha C et al (2010) Deregulation of HIF1-alpha and hypoxia-regulated pathways in hepatocellular carcinoma and corresponding non-malignant liver tissue\u2014influence of a modulated host stroma on the prognosis of HCC. Langenbecks Arch Surg 395:395\u2013405","journal-title":"Langenbecks Arch Surg"},{"key":"1408_CR135","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1007\/s11033-011-0949-1","volume":"39","author":"ZL Xiang","year":"2012","unstructured":"Xiang ZL, Zeng ZC, Fan J et al (2012) The expression of HIF-1alpha in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome. Mol Biol Rep 39:2021\u20132029","journal-title":"Mol Biol Rep"},{"key":"1408_CR136","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/jjco\/hyt194","volume":"44","author":"SL Yang","year":"2014","unstructured":"Yang SL, Liu LP, Jiang JX et al (2014) The correlation of expression levels of HIF-1alpha and HIF-2alpha in hepatocellular carcinoma with capsular invasion, portal vein tumor thrombi and patients\u2019 clinical outcome. Jpn J Clin Oncol 44:159\u2013167","journal-title":"Jpn J Clin Oncol"},{"key":"1408_CR137","doi-asserted-by":"publisher","first-page":"e65753","DOI":"10.1371\/journal.pone.0065753","volume":"8","author":"SS Zheng","year":"2013","unstructured":"Zheng SS, Chen XH, Yin X, Zhang BH (2013) Prognostic significance of HIF-1alpha expression in hepatocellular carcinoma: a meta-analysis. PLoS One 8:e65753","journal-title":"PLoS One"},{"key":"1408_CR138","doi-asserted-by":"publisher","first-page":"11846","DOI":"10.1038\/srep11846","volume":"5","author":"X Guo","year":"2015","unstructured":"Guo X, Li D, Chen Y et al (2015) SNP rs2057482 in HIF1A gene predicts clinical outcome of aggressive hepatocellular carcinoma patients after surgery. Sci Rep 5:11846","journal-title":"Sci Rep"},{"key":"1408_CR139","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/jso.21539","volume":"102","author":"PC Hsiao","year":"2010","unstructured":"Hsiao PC, Chen MK, Su SC et al (2010) Hypoxia inducible factor-1alpha gene polymorphism G1790A and its interaction with tobacco and alcohol consumptions increase susceptibility to hepatocellular carcinoma. J Surg Oncol 102:163\u2013169","journal-title":"J Surg Oncol"},{"key":"1408_CR140","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1111\/j.1440-1746.2007.04997.x","volume":"22","author":"XZ Wu","year":"2007","unstructured":"Wu XZ, Xie GR, Chen D (2007) Hypoxia and hepatocellular carcinoma: the therapeutic target for hepatocellular carcinoma. J Gastroenterol Hepatol 22:1178\u20131182","journal-title":"J Gastroenterol Hepatol"},{"key":"1408_CR141","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1007\/s10620-008-0296-9","volume":"53","author":"H Xie","year":"2008","unstructured":"Xie H, Song J, Liu K et al (2008) The expression of hypoxia-inducible factor-1alpha in hepatitis B virus-related hepatocellular carcinoma: correlation with patients\u2019 prognosis and hepatitis B virus X protein. Dig Dis Sci 53:3225\u20133233","journal-title":"Dig Dis Sci"},{"key":"1408_CR142","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1124\/mol.106.027029","volume":"70","author":"Q Ke","year":"2006","unstructured":"Ke Q, Costa M (2006) Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 70:1469\u20131480","journal-title":"Mol Pharmacol"},{"key":"1408_CR143","first-page":"409272","volume":"2014","author":"D Luo","year":"2014","unstructured":"Luo D, Wang Z, Wu J, Jiang C, Wu J (2014) The role of hypoxia inducible factor-1 in hepatocellular carcinoma. Biomed Res Int 2014:409272","journal-title":"Biomed Res Int"},{"key":"1408_CR144","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","volume":"3","author":"GL Semenza","year":"2003","unstructured":"Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721\u2013732","journal-title":"Nat Rev Cancer"},{"key":"1408_CR145","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1093\/carcin\/bgs249","volume":"33","author":"L Xia","year":"2012","unstructured":"Xia L, Mo P, Huang W et al (2012) The TNF-alpha\/ROS\/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis. Carcinogenesis 33:2250\u20132259","journal-title":"Carcinogenesis"},{"key":"1408_CR146","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1582-4934.2007.00030.x","volume":"11","author":"BM Putzer","year":"2007","unstructured":"Putzer BM (2007) E2F1 death pathways as targets for cancer therapy. J Cell Mol Med 11:239\u2013251","journal-title":"J Cell Mol Med"},{"key":"1408_CR147","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/hep.26188","volume":"57","author":"HX Sun","year":"2013","unstructured":"Sun HX, Xu Y, Yang XR et al (2013) Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3\/ E2F transcription factor 1-dependent apoptotic pathway. Hepatology 57:1088\u20131097","journal-title":"Hepatology"},{"key":"1408_CR148","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/28867","volume":"394","author":"P Carmeliet","year":"1998","unstructured":"Carmeliet P, Dor Y, Herbert JM et al (1998) Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394:485\u2013490","journal-title":"Nature"},{"key":"1408_CR149","doi-asserted-by":"publisher","first-page":"8927","DOI":"10.1158\/0008-5472.CAN-06-1501","volume":"66","author":"JW Kim","year":"2006","unstructured":"Kim JW, Dang CV (2006) Cancer\u2019s molecular sweet tooth and the Warburg effect. Cancer Res 66:8927\u20138930","journal-title":"Cancer Res"},{"key":"1408_CR150","doi-asserted-by":"crossref","first-page":"23757","DOI":"10.1016\/S0021-9258(17)31580-6","volume":"269","author":"GL Semenza","year":"1994","unstructured":"Semenza GL, Roth PH, Fang HM, Wang GL (1994) Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269:23757\u201323763","journal-title":"J Biol Chem"},{"key":"1408_CR151","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10863-007-9081-2","volume":"39","author":"GL Semenza","year":"2007","unstructured":"Semenza GL (2007) HIF-1 mediates the Warburg effect in clear cell renal carcinoma. J Bioenerg Biomembr 39:231\u2013234","journal-title":"J Bioenerg Biomembr"},{"key":"1408_CR152","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1128\/MCB.21.10.3436-3444.2001","volume":"21","author":"TN Seagroves","year":"2001","unstructured":"Seagroves TN, Ryan HE, Lu H et al (2001) Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells. Mol Cell Biol 21:3436\u20133444","journal-title":"Mol Cell Biol"},{"key":"1408_CR153","first-page":"1047","volume":"6","author":"J Josko","year":"2000","unstructured":"Josko J, Gwozdz B, Jedrzejowska-Szypulka H, Hendryk S (2000) Vascular endothelial growth factor (VEGF) and its effect on angiogenesis. Med Sci Monit 6:1047\u20131052","journal-title":"Med Sci Monit"},{"key":"1408_CR154","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3350\/kjhep.2010.16.3.278","volume":"16","author":"JW Kim","year":"2010","unstructured":"Kim JW (2010) Hypoxia-inducible factor 1, hepatocellular carcinoma and angiogenesis. Korean J Hepatol 16:278\u2013279","journal-title":"Korean J Hepatol"},{"key":"1408_CR155","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/cvr\/cvq045","volume":"86","author":"S Rey","year":"2010","unstructured":"Rey S, Semenza GL (2010) Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc Res 86:236\u2013242","journal-title":"Cardiovasc Res"},{"key":"1408_CR156","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/S0002-9440(10)63501-8","volume":"163","author":"T Imai","year":"2003","unstructured":"Imai T, Horiuchi A, Wang C et al (2003) Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. Am J Pathol 163:1437\u20131447","journal-title":"Am J Pathol"},{"key":"1408_CR157","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1158\/0008-5472.CAN-05-3719","volume":"66","author":"B Krishnamachary","year":"2006","unstructured":"Krishnamachary B, Zagzag D, Nagasawa H et al (2006) Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res 66:2725\u20132731","journal-title":"Cancer Res"},{"key":"1408_CR158","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ncb1691","volume":"10","author":"MH Yang","year":"2008","unstructured":"Yang MH, Wu MZ, Chiou SH et al (2008) Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 10:295\u2013305","journal-title":"Nat Cell Biol"},{"key":"1408_CR159","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1471-2407-13-108","volume":"13","author":"L Zhang","year":"2013","unstructured":"Zhang L, Huang G, Li X et al (2013) Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1alpha in hepatocellular carcinoma. BMC Cancer 13:108","journal-title":"BMC Cancer"},{"key":"1408_CR160","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/hep.23221","volume":"50","author":"MH Yang","year":"2009","unstructured":"Yang MH, Chen CL, Chau GY et al (2009) Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology 50:1464\u20131474","journal-title":"Hepatology"},{"key":"1408_CR161","doi-asserted-by":"publisher","first-page":"753","DOI":"10.2174\/187152012802650165","volume":"12","author":"I Okazaki","year":"2012","unstructured":"Okazaki I, Inagaki Y (2012) Novel strategies for hepatocellular carcinoma based on MMPs science. Anticancer Agents Med Chem 12:753\u2013763","journal-title":"Anticancer Agents Med Chem"},{"key":"1408_CR162","first-page":"77","volume":"7","author":"H Sato","year":"1992","unstructured":"Sato H, Kida Y, Mai M et al (1992) Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 7:77\u201383","journal-title":"Oncogene"},{"key":"1408_CR163","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.brainres.2009.02.060","volume":"1268","author":"JY Ding","year":"2009","unstructured":"Ding JY, Kreipke CW, Schafer P et al (2009) Synapse loss regulated by matrix metalloproteinases in traumatic brain injury is associated with hypoxia inducible factor-1alpha expression. Brain Res 1268:125\u2013134","journal-title":"Brain Res"},{"key":"1408_CR164","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1159\/000318806","volume":"48","author":"OJ Erdozain","year":"2011","unstructured":"Erdozain OJ, Pegrum S, Winrow VR, Horrocks M, Stevens CR (2011) Hypoxia in abdominal aortic aneurysm supports a role for HIF-1alpha and Ets-1 as drivers of matrix metalloproteinase upregulation in human aortic smooth muscle cells. J Vasc Res 48:163\u2013170","journal-title":"J Vasc Res"},{"key":"1408_CR165","first-page":"793","volume":"30","author":"S Fujiwara","year":"2007","unstructured":"Fujiwara S, Nakagawa K, Harada H et al (2007) Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas. Int J Oncol 30:793\u2013802","journal-title":"Int J Oncol"},{"key":"1408_CR166","first-page":"1764","volume":"63","author":"HJ Knowles","year":"2003","unstructured":"Knowles HJ, Raval RR, Harris AL, Ratcliffe PJ (2003) Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Res 63:1764\u20131768","journal-title":"Cancer Res"},{"key":"1408_CR167","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/82146","volume":"6","author":"AL Kung","year":"2000","unstructured":"Kung AL, Wang S, Klco JM, Kaelin WG, Livingston DM (2000) Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat Med 6:1335\u20131340","journal-title":"Nat Med"},{"key":"1408_CR168","doi-asserted-by":"publisher","first-page":"12171","DOI":"10.3748\/wjg.v21.i42.12171","volume":"21","author":"D Lin","year":"2015","unstructured":"Lin D, Wu J (2015) Hypoxia inducible factor in hepatocellular carcinoma: a therapeutic target. World J Gastroenterol 21:12171\u201312178","journal-title":"World J Gastroenterol"},{"key":"1408_CR169","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1158\/0008-5472.CAN-03-3139","volume":"64","author":"A Rapisarda","year":"2004","unstructured":"Rapisarda A, Uranchimeg B, Sordet O et al (2004) Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications. Cancer Res 64:1475\u20131482","journal-title":"Cancer Res"},{"key":"1408_CR170","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.surg.2012.03.003","volume":"152","author":"Y Abe","year":"2012","unstructured":"Abe Y, Uchinami H, Kudoh K et al (2012) Liver epithelial cells proliferate under hypoxia and protect the liver from ischemic injury via expression of HIF-1 alpha target genes. Surgery 152:869\u2013878","journal-title":"Surgery"},{"key":"1408_CR171","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/j.1478-3231.2005.01144.x","volume":"25","author":"H Maeno","year":"2005","unstructured":"Maeno H, Ono T, Dhar DK et al (2005) Expression of hypoxia inducible factor-1alpha during liver regeneration induced by partial hepatectomy in rats. Liver Int 25:1002\u20131009","journal-title":"Liver Int"},{"key":"1408_CR172","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.bbrc.2009.07.115","volume":"387","author":"T Tajima","year":"2009","unstructured":"Tajima T, Goda N, Fujiki N et al (2009) HIF-1alpha is necessary to support gluconeogenesis during liver regeneration. Biochem Biophys Res Commun 387:789\u2013794","journal-title":"Biochem Biophys Res Commun"},{"key":"1408_CR173","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3892\/ol.2015.3315","volume":"10","author":"F Liu","year":"2015","unstructured":"Liu F, Dong X, Lv H et al (2015) Targeting hypoxia-inducible factor-2alpha enhances sorafenib antitumor activity via beta-catenin\/C-Myc-dependent pathways in hepatocellular carcinoma. Oncol Lett 10:778\u2013784","journal-title":"Oncol Lett"},{"key":"1408_CR174","doi-asserted-by":"publisher","first-page":"5585","DOI":"10.1158\/1078-0432.CCR-12-0858","volume":"18","author":"TW Meijer","year":"2012","unstructured":"Meijer TW, Kaanders JH, Span PN, Bussink J (2012) Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy. Clin Cancer Res 18:5585\u20135594","journal-title":"Clin Cancer Res"},{"key":"1408_CR175","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1158\/1541-7786.MCR-10-0469","volume":"9","author":"DL Schwartz","year":"2011","unstructured":"Schwartz DL, Bankson J, Bidaut L et al (2011) HIF-1-dependent stromal adaptation to ischemia mediates in vivo tumor radiation resistance. Mol Cancer Res 9:259\u2013270","journal-title":"Mol Cancer Res"},{"key":"1408_CR176","doi-asserted-by":"publisher","first-page":"e88913","DOI":"10.1371\/journal.pone.0088913","volume":"9","author":"L Wu","year":"2014","unstructured":"Wu L, Fu Z, Zhou S et al (2014) HIF-1alpha and HIF-2alpha: siblings in promoting angiogenesis of residual hepatocellular carcinoma after high-intensity focused ultrasound ablation. PLoS One 9:e88913","journal-title":"PLoS One"},{"issue":"Suppl 3","key":"1408_CR177","doi-asserted-by":"publisher","first-page":"S436","DOI":"10.1245\/s10434-014-3575-z","volume":"21","author":"S Yamada","year":"2014","unstructured":"Yamada S, Utsunomiya T, Morine Y et al (2014) Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy. Ann Surg Oncol 21(Suppl 3):S436\u2013S442","journal-title":"Ann Surg Oncol"},{"key":"1408_CR178","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.cellsig.2014.01.026","volume":"26","author":"D Zhao","year":"2014","unstructured":"Zhao D, Zhai B, He C et al (2014) Upregulation of HIF-2alpha induced by sorafenib contributes to the resistance by activating the TGF-alpha\/EGFR pathway in hepatocellular carcinoma cells. Cell Signal 26:1030\u20131039","journal-title":"Cell Signal"},{"key":"1408_CR179","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1002\/hep.26224","volume":"57","author":"Y Liang","year":"2013","unstructured":"Liang Y, Zheng T, Song R et al (2013) Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1alpha inhibition in hepatocellular carcinoma. Hepatology 57:1847\u20131857","journal-title":"Hepatology"},{"key":"1408_CR180","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1111\/j.1349-7006.2008.00905.x","volume":"99","author":"F Liu","year":"2008","unstructured":"Liu F, Wang P, Jiang X et al (2008) Antisense hypoxia-inducible factor 1alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma. Cancer Sci 99:2055\u20132061","journal-title":"Cancer Sci"},{"key":"1408_CR181","doi-asserted-by":"publisher","first-page":"e1001665","DOI":"10.1371\/journal.pbio.1001665","volume":"11","author":"T Eckle","year":"2013","unstructured":"Eckle T, Brodsky K, Bonney M et al (2013) HIF1A reduces acute lung injury by optimizing carbohydrate metabolism in the alveolar epithelium. PLoS Biol 11:e1001665","journal-title":"PLoS Biol"},{"key":"1408_CR182","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1053\/j.gastro.2007.12.008","volume":"134","author":"H Hartmann","year":"2008","unstructured":"Hartmann H, Eltzschig HK, Wurz H et al (2008) Hypoxia-independent activation of HIF-1 by enterobacteriaceae and their siderophores. Gastroenterology 134:756\u2013767","journal-title":"Gastroenterology"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-016-1408-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-016-1408-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-016-1408-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-016-1408-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T17:24:32Z","timestamp":1718472272000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-016-1408-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,20]]},"references-count":182,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["1408"],"URL":"https:\/\/doi.org\/10.1007\/s00109-016-1408-1","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,20]]},"assertion":[{"value":"3 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}